title: Back to the future: the managed care approach to rheumatoid arthritis.
abstract: Biologic disease-modifying antirheumatic drugs have been proven effective in the treatment of rheumatoid arthritis, but their efficacy literally comes at quite a high price to health plans. Therefore, MCOs are examining various strategies to provide coverage for these agents in a more cost-effective manner.
authors.affiliation: Geisinger Health System, Danville, Pennsylvania, USA. jaans@aol.com
authors.forename: Jaan
authors.initials: J
authors.lastname: Sidorov
mesh_terms: D018501:Antirheumatic Agents / Q000191:economics* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001691:Biological Therapy; D006801:Humans; D019458:Insurance Coverage; D008329:Managed Care Programs; D014481:United States
chemical_list: D018501:Antirheumatic Agents